Purchase Order 36C25725P0482

Award Date 6/19/25
Potential Completion Date 6/18/30
Potential Value $497K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Temple, TX 76504, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $164,980.62 contract provides reagents to support whole genome sequencing using Illumina's MiSeq and NextSeq 2000 platforms, with a performance period through December 2023. The contract has no set-aside designation. Illumina is a well-established provider of sequencing solutions to federal agencies, having received...
This firm fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $150,974.70 contract is for a "MOLECULAR NEXT GENERATION SYSTEM" under an Other Transaction Authority (OT) agreement and does not have a set-aside designation. Illumina has previously received prime federal contracts and sub-grants from agencies like the National Institutes of Health, Centers...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments, to provide an NGS (Next Generation Sequencing) platform. The $162,825 contract has a completion date of September 30, 2021 and does not include any set-aside designation. Through previous prime federal contract awards, Illumina has supplied a range of its sequencing platforms, reagents,...
This is a $198,000.00 firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents for genetic and genomic analysis. The contract is for whole genome sequencing services and does not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics across various federal agencies like the...
This is a firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing equipment and analytical instruments. The contract, valued at $275,227.48, is for the provision of sequencing equipment and related goods and services. Illumina has a history of providing sequencing systems, reagents, and bioinformatics support to various federal agencies, including the...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $157,400.64 contract is for the delivery of multi-ethnic genotyping kits, with a completion date of May 8, 2018. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, CDC, USDA, and VA for genomic...
This is a firm fixed-price delivery order awarded by a civilian federal agency to Illumina, Inc., a leading manufacturer and provider of genetic sequencing and genomic analysis technologies. The contract is for the procurement of NextSeq 500/550 High Output Kits, with a ceiling value of $167,409.46 and a performance period through May 2025. The award does not utilize any set-aside designations. Illumina holds multiple indefinite delivery vehicle (IDV) contracts with the Department of Veterans...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for research related to the InfiniumR methylation platform, with a ceiling value of $93,963.52 and a performance period ending on January 12, 2017. The contract does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various agencies such...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $195,464.40 contract provides for Illumina Sequencers Service Agreement, which includes the procurement of advanced sequencing instruments like NextSeq, NovaSeq, MiSeq, and iSeq systems, along with associated reagents,...
This federal contract award is for the purchase of a NEXTSEQ 550 SEQUENCING SYSTEM by the Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The firm fixed-price contract, valued at $354,024.55, does not have a set-aside designation. Illumina has provided similar sequencing systems and consumables to other federal agencies such as the National Institutes of...

This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not have a set-aside designation.

Illumina has been awarded multiple prime federal contracts and grants across various agencies, including the VA, National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration, primarily for the procurement of its advanced genomic sequencing platforms and services. This contract appears to be part of the VA's efforts to leverage Illumina's technology for genomic research and diagnostic applications. The contract is also linked to two Illumina Indefinite Delivery Vehicles (IDVs) with the VA, valued at $231,165 and $1,297,062, respectively, which provide additional flexibility for the agency to order Illumina's products and services as needed.

Generated 6/13/25, 9:58 AM